- Home
- DXCM vs MKL Comparison
DXCM vs MKL Comparison
Compare DXCM & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DXCM | MKL |
|---|---|---|
| Founded | 1999 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1B | 23.2B |
| IPO Year | 2005 | 1999 |
Fundamental Metrics
Financial Performance| Metric | DXCM | MKL |
|---|---|---|
| Price | $72.13 | $1,859.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 1 |
| Target Price | $85.33 | ★ $2,100.00 |
| AVG Volume (30 Days) | ★ 5.4M | 69.2K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.18 | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | ★ $15,513,233,000.00 |
| Revenue This Year | $14.46 | N/A |
| Revenue Next Year | $12.31 | $2.26 |
| P/E Ratio | $139.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $54.11 | $1,719.41 |
| 52 Week High | $89.07 | $2,207.59 |
Technical Indicators
Market Signals| Indicator | DXCM | MKL |
|---|---|---|
| Relative Strength Index (RSI) | 52.70 | 54.12 |
| Support Level | $62.86 | $1,812.24 |
| Resistance Level | $74.08 | $1,876.58 |
| Average True Range (ATR) | 2.81 | 31.37 |
| MACD | -0.65 | 8.80 |
| Stochastic Oscillator | 15.11 | 68.19 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
About MKL Markel Group Inc.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.